| All patients (n = 107) | Group 1 (n = 39) | Group 2 (n = 31) | Group 3 (n = 37) | p |
---|---|---|---|---|---|
Age (years) | 45.8 ± 10.9 | 44.2 ± 10.3 | 46.5 ± 11.2 | 44.2 ± 11.8 | n.s. |
Follow-up (mean, months) | 172.8 ± 31.8 | 174.1 ± 29.4 | 162.4 ± 31.7 | 177.5 ± 34.7 | n.s. |
Sex (male/female) | 8/99 | 3/37 | 2/29 | 3/34 | n.s. |
BMI (kg/m2) | 28.0 ± 3.8 | 27.6 ± 4.1 | 28.8 ± 3.0 | 28.0 ± 4.0 | n.s. |
Smoker/non-smoker | 19/88 | 8/31 | 6/25 | 5/32 | n.s. |
Crowe Classification ( 3 / 4 ) | 12/95 | 5/34 | 3/28 | 4/33 | n.s. |
Dorr types (A/B/C) | 41/66/0 | 19/20/0 | 12/19/0 | 13/24/0 | n.s. |